Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab′ fragments and single chain Fv
- 18 February 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 126 (1), 50-58
- https://doi.org/10.1016/j.jconrel.2007.11.005
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Preclinical Manufacture of Anti-HER2 Liposome-Inserting, scFv-PEG-Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency AnalysisBiotechnology Progress, 2008
- Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and PurificationBiotechnology Progress, 2008
- Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cellsMolecular Cancer Therapeutics, 2007
- Expression and purification of two anti-CD19 single chain Fv fragments for targeting of liposomes to CD19-expressing cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Antinucleosome Antibody-Modified Liposomes and Lipid-Core Micelles for Tumor-Targeted Delivery of Therapeutic and Diagnostic AgentsJournal of Liposome Research, 2007
- Thioredoxin Fusions Increase Folding of Single Chain Fv Antibodies in the Cytoplasm of Escherichia coli: Evidence that Chaperone Activity is the Prime Effect of ThioredoxinJournal of Molecular Biology, 2006
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Phase III data on Caelyx® in ovarian cancerEuropean Journal of Cancer, 2001
- Stability engineering of antibody single-chain Fv fragmentsJournal of Molecular Biology, 2001
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996